Activation of the Respiratory Syncytial virus fusion protein [ 2012 - 2015 ]

Research Grant

Researchers: Prof Paul Young (Principal investigator) ,  A/Pr Stuart Kellie

Brief description Respiratory Syncytial Virus (RSV) is the most important viral cause of respiratory tract disease in both infants and the elderly. However, there are few available options for control, whether by vaccination or therapeutic intervention. This proposal investigates the way RSV infects cells. A clearer understanding of the molecular basis of this process should provide potential targets for new drugs that can block this process and new insights for the generation of vaccine candidates.

Funding Amount $AUD 582,072.03

Funding Scheme Project Grants

Notes Standard Project Grant